𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levels of 5-hydroxymethyl-2′-deoxyuridine in DNA from blood as a marker of breast cancer

✍ Scribed by Zora Djuric; Lance K. Heilbrun; Michael S. Simon; Daryn Smith; Domenico A. Luongo; Patricia M. LoRusso; Silvana Martino


Book ID
102649309
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
565 KB
Volume
77
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


BACKGROUND.

Oxidative DNA damage can result from numerous endogenous metabolic processes as well as from exposure to environmental and dietary oxidants. One important type of oxidative DNA damage is the formation of hydroxylated DNA bases. This type of DNA damage may have a role in carcinogenesis. METHODS. We examined the levels of a hydroxylated thymine residue, 5-hydroxyrnethyl-Z'-deoxyuridine, in DNA obtained from the peripheral blood of breast cancer patients and control women. The isolated DNA was analyzed for levels of 5hydroxymethyl-2'-deoxyuridine by gas chromatography with mass spectral detection.

RESULTS.

The levels of this modified base were significantly higher in 25 breast cancer patients compared with 38 controls, with levels of 0.112 2 0.046 in the cancer patients versus 0.083 2 0.025 in the controls, given as pg 5-hydroxymethyl-Z'-deoxyuridine/ng thymidine, mean 2 standard deviation ( P = 0.019). After controlling for various covariates, the adjusted mean levels of oxidative DNA damage were still significantly higher in women with breast cancer relative to controls.

CONCLUSIONS.

These results indicate that the levels of 5-hydroxymethyl-Z'-deoxyuridine in DNA from peripheral nucleated blood may be potentially useful as a marker of breast cancer.


📜 SIMILAR VOLUMES